NCT05192863View on ClinicalTrials.gov

A Study of Vedolizumab in Adults With Crohn's Disease (CD)

Active, not recruitingOBSERVATIONAL
Enrollment

72

Participants

Timeline

Start Date

March 20, 2023

Primary Completion Date

October 31, 2025

Study Completion Date

October 31, 2025

Conditions
Crohn's Disease
Interventions
OTHER

No Intervention

This is a non-interventional study.

Trial Locations (10)

20017

Ospedale ASST Rhodense, Rho

20122

Fondazione Ca' Granda Ospedale Maggiore Policlinico, Milan

20132

Ospedale San Raffaele, Milan

20157

ASST Fatebenefratelli Sacco, Milan

80131

A.O.U. Federico II, Napoli

4941492

Rabin Medical Center, Petah Tikva

5262000

Sheba Medical Center, Ramat Gan

9112001

Hadassah Medical Center, Jerusalem

T2N 4N1

University of Calgary, Calgary

S7N 0W8

University of Saskatchewan, Saskatoon

Sponsors

Lead Sponsor

Takeda
All Listed Sponsors
lead

Takeda

INDUSTRY

NCT05192863 - A Study of Vedolizumab in Adults With Crohn's Disease (CD) | Biotech Hunter | Biotech Hunter